scholarly journals Anti-Cancer Effects of Panax ginseng Berry Polysaccharides via Activation of Immune-Related Cells

2019 ◽  
Vol 10 ◽  
Author(s):  
Dae-Young Lee ◽  
Chan Woong Park ◽  
Sue Jung Lee ◽  
Hye-Ryung Park ◽  
Su Hwan Kim ◽  
...  
Keyword(s):  
2019 ◽  
Vol 19 (25) ◽  
pp. 2334-2347 ◽  
Author(s):  
Yu-hang Guo ◽  
Revathimadhubala Kuruganti ◽  
Ying Gao

The dried root of ginseng (Panax ginseng C. A. Meyer or Panax quinquefolius L.) is a traditional Chinese medicine widely used to manage cancer symptoms and chemotherapy side effects in Asia. The anti-cancer efficacy of ginseng is attributed mainly to the presence of saponins, which are commonly known as ginsenosides. Ginsenosides were first identified as key active ingredients in Panax ginseng and subsequently found in Panax quinquefolius, both of the same genus. To review the recent advances on anti-cancer effects of ginsenosides against breast cancer, we conducted a literature study of scientific articles published from 2010 through 2018 to date by searching the major databases including Pubmed, SciFinder, Science Direct, Springer, Google Scholar, and CNKI. A total of 50 articles authored in either English or Chinese related to the anti-breast cancer activity of ginsenosides have been reviewed, and the in vitro, in vivo, and clinical studies on ginsenosides are summarized. This review focuses on how ginsenosides exert their anti-breast cancer activities through various mechanisms of action such as modulation of cell growth, modulation of the cell cycle, modulation of cell death, inhibition of angiogenesis, inhibition of metastasis, inhibition of multidrug resistance, and cancer immunemodulation. In summary, recent advances in the evaluation of ginsenosides as therapeutic agents against breast cancer support further pre-clinical and clinical studies to treat primary and metastatic breast tumors.


Molecules ◽  
2020 ◽  
Vol 25 (21) ◽  
pp. 4905
Author(s):  
Maryam Nakhjavani ◽  
Eric Smith ◽  
Amanda R. Townsend ◽  
Timothy J. Price ◽  
Jennifer E. Hardingham

Ginsenoside Rg3 (Rg3) is a member of the ginsenoside family of chemicals extracted from Panax ginseng. Like other ginsenosides, Rg3 has two epimers: 20(S)-ginsenoside Rg3 (SRg3) and 20(R)-ginsenoside Rg3 (RRg3). Rg3 is an intriguing molecule due to its anti-cancer properties. One facet of the anti-cancer properties of Rg3 is the anti-angiogenic action. This review describes the controversies on the effects and effective dose range of Rg3, summarizes the evidence on the efficacy of Rg3 on angiogenesis, and raises the possibility that Rg3 is a prodrug.


2011 ◽  
Vol 66 (3) ◽  
pp. 298-305 ◽  
Author(s):  
Ju-Hee Kang ◽  
Ki-Hoon Song ◽  
Jong-Kyu Woo ◽  
Myung Hwan Park ◽  
Man Hee Rhee ◽  
...  

Processes ◽  
2021 ◽  
Vol 9 (8) ◽  
pp. 1344
Author(s):  
Sejin Kim ◽  
Nayeon Kim ◽  
JaYeon Jeong ◽  
Soojin Lee ◽  
Woojin Kim ◽  
...  

Cancer incidence and mortality rate are growing worldwide. The effectiveness of cancer therapy depends on the degree of cancer development. Anticancer prevention, screening tests, detection of precancerous conditions or cancers at an early stage of development help to prevent the development of cancer, and in the event of cancer development, they provide the best chance for a full recovery. However, in most cases of advanced cancer, there is no method that can fully cure this disease. Recently, natural products have gained more attention in cancer therapy. Panax ginseng (PG), one of the most popular natural products, is reported to have a wide range of pharmacological activities in cancer. Therefore, the anti-cancer effects and mechanisms of PG and its metabolites (compound K, Ginsenoside Rh1, Rh2, Rh3 and F1) in five major cancers (lung cancer, breast cancer, colon cancer, prostate cancer and stomach cancer) are reviewed in this study. It is confirmed that PG and its metabolites regulated apoptosis, epithelial mesenchymal transition (EMT), angiogenesis, cell cycle arrest and multidrug resistance (MDR) in vitro and in vivo cancer models. In particular, ginsenoside Rh2 showed anticancer effects in all five major cancers. This review could improve the understanding of anticancer mechanisms of PG and its metabolites against major five cancers. Further clinical studies are needed for development anti-cancer drugs using PG and its metabolites.


PLoS ONE ◽  
2016 ◽  
Vol 11 (2) ◽  
pp. e0147183 ◽  
Author(s):  
Jian Xiao ◽  
Dan Chen ◽  
Xiu-Xian Lin ◽  
Shi-Fang Peng ◽  
Mei-Fang Xiao ◽  
...  

Author(s):  
T.V.M. Sreekanth ◽  
P.C. Nagajyothi ◽  
P. Muthuraman ◽  
G. Enkhtaivan ◽  
S.V.P. Vattikuti ◽  
...  

2006 ◽  
Vol 59 (5) ◽  
pp. 589-601 ◽  
Author(s):  
Wei Wang ◽  
Yuqing Zhao ◽  
Elizabeth R. Rayburn ◽  
Donald L. Hill ◽  
Hui Wang ◽  
...  

2018 ◽  
Vol 13 (10) ◽  
pp. 1934578X1801301 ◽  
Author(s):  
Quang-Ung Le ◽  
Horng-Liang Lay ◽  
Ming-Chang Wu ◽  
Thi Hong-Hanh Nguyen ◽  
Duy-Lam Nguyen

Panax vietnamensis Ha et Grushv., a Vietnamese ginseng, is a well-known plant, naturally distributed in the Ngoc Linh and Hoang Lien Son mountain areas in Vietnam. It is used as a tonic and medicinal food in traditional folk medicine because it possesses wondrous health benefits. To support its functional attributes, various investigations have been carried out to find out its anti-inflammatory, anti-cancer, anti-stress, anti-nociception, psychomotor and sedative-hypnotic effects and anxiolytic activities. Also similar to other ginsengs, Vietnamese ginseng is a rich source of saponins and it has higher content of protopanaxadiol-, protopanaxatrial- and ocotillol-type saponins compared to other ginsengs in the world. Majonoside R2 is a main saponin in Vietnamese ginseng but this compound does not exist in Panax ginseng. Based on this systematic review, we discussed for future prospects and suggest that thorough scientific scrutiny is necessary in future researches.


Sign in / Sign up

Export Citation Format

Share Document